A detailed history of Royce & Associates LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 181,394 shares of CTKB stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
181,394
Previous 119,478 51.82%
Holding current value
$1.17 Million
Previous $666,000 50.75%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$4.73 - $6.73 $292,862 - $416,694
61,916 Added 51.82%
181,394 $1 Million
Q2 2024

Aug 13, 2024

BUY
$5.3 - $6.91 $573,078 - $747,164
108,128 Added 952.67%
119,478 $666,000
Q1 2024

May 13, 2024

BUY
$6.29 - $9.15 $71,391 - $103,852
11,350 New
11,350 $76,000
Q3 2023

Nov 09, 2023

BUY
$5.52 - $9.5 $83,953 - $144,485
15,209 Added 21.04%
87,489 $482,000
Q2 2023

Aug 07, 2023

BUY
$6.69 - $11.99 $186,423 - $334,113
27,866 Added 62.74%
72,280 $617,000
Q1 2023

May 04, 2023

BUY
$8.44 - $13.47 $374,854 - $598,256
44,414 New
44,414 $408,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $870M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.